Russell Frank Company’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-7,429
Closed -$94K 3460
2013
Q3
$94K Sell
7,429
-46
-0.6% -$610 ﹤0.01% 2968
2013
Q2
$103K Buy
+7,475
New +$109K ﹤0.01% 2741

Russell Frank Company's OPTR Position: Q4 2013 in Review

Russell Frank Company sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 7,429 shares — an estimated $94K sold.

Russell Frank Company first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $103K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Russell Frank Company reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 7,429 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $94K.
  • Russell Frank Company first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Russell Frank Company's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $103K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.